Alene McCoy, Ph.D. - Publications

Affiliations: 
2010 Washington State University, Pullman, WA, United States 

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Terry C, Hays S, McCoy AT, McFadden LG, Aggarwal M, Rasoulpour RJ, Juberg DR. Implementing a Framework for Integrating Toxicokinetics into Human Health Risk Assessment for Agrochemicals. Regulatory Toxicology and Pharmacology : Rtp. PMID 26472101 DOI: 10.1016/j.yrtph.2015.10.003  0.72
2013 McCoy AT, Benoist CC, Wright JW, Kawas LH, Bule-Ghogare JM, Zhu M, Appleyard SM, Wayman GA, Harding JW. Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents. The Journal of Pharmacology and Experimental Therapeutics. 344: 141-54. PMID 23055539 DOI: 10.1124/jpet.112.199497  0.72
2012 Saghir SA, Khan SA, McCoy AT. Ontogeny of mammalian metabolizing enzymes in humans and animals used in toxicological studies. Critical Reviews in Toxicology. 42: 323-57. PMID 22512665 DOI: 10.3109/10408444.2012.674100  0.72
2012 McCoy AT, Bartels MJ, Rick DL, Saghir SA. TK Modeler version 1.0, a Microsoft® Excel®-based modeling software for the prediction of diurnal blood/plasma concentration for toxicokinetic use. Regulatory Toxicology and Pharmacology : Rtp. 63: 333-43. PMID 22504463 DOI: 10.1016/j.yrtph.2012.04.002  0.72
2012 Saghir SA, Bartels MJ, Rick DL, McCoy AT, Rasoulpour RJ, Ellis-Hutchings RG, Sue Marty M, Terry C, Bailey JP, Billington R, Bus JS. Assessment of diurnal systemic dose of agrochemicals in regulatory toxicity testing--an integrated approach without additional animal use. Regulatory Toxicology and Pharmacology : Rtp. 63: 321-32. PMID 22440553 DOI: 10.1016/j.yrtph.2012.03.004  0.72
2012 Kawas LH, McCoy AT, Yamamoto BJ, Wright JW, Harding JW. Development of angiotensin IV analogs as hepatocyte growth factor/Met modifiers. The Journal of Pharmacology and Experimental Therapeutics. 340: 539-48. PMID 22129598 DOI: 10.1124/jpet.111.188136  0.72
2010 Yamamoto BJ, Elias PD, Masino JA, Hudson BD, McCoy AT, Anderson ZJ, Varnum MD, Sardinia MF, Wright JW, Harding JW. The angiotensin IV analog Nle-Tyr-Leu-psi-(CH2-NH2)3-4-His-Pro-Phe (norleual) can act as a hepatocyte growth factor/c-Met inhibitor. The Journal of Pharmacology and Experimental Therapeutics. 333: 161-73. PMID 20086056 DOI: 10.1124/jpet.109.161711  0.72
Show low-probability matches.